Rocket Pharmaceuticals, Inc. (RCKT)

Rocket Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	65.6	55.9	140.52	232.69	297.1	185.38
Short-Term Investments	170.06	317.27	215.88	156.05	185.62	118.73
Cash & Short-Term Investments	235.66	373.18	356.39	388.74	482.72	304.12
Cash Growth	-46.09%	4.71%	-8.32%	-19.47%	58.73%	47.82%
Other Receivables	-	0.05	-	-	-	-
Receivables	-	0.05	-	-	-	-
Prepaid Expenses	6.09	5	7.67	3.32	4.63	3.64
Total Current Assets	241.75	378.22	364.06	392.06	487.35	307.75
Property, Plant & Equipment	85.77	87.59	77.65	72.35	70.64	31.57
Long-Term Investments	-	34.32	43.28	-	-	-
Goodwill	39.15	39.15	39.15	30.82	30.82	30.82
Other Intangible Assets	25.15	25.15	25.72	-	-	-
Other Long-Term Assets	1.87	1.91	1.95	1.8	2.02	1.98
Total Assets	393.69	566.34	551.81	497.02	590.82	372.12
Accounts Payable	2.77	1.77	2.27	0.48	0.84	0.34
Accrued Expenses	34.1	29.8	30.54	17.81	22.29	11.8
Current Portion of Long-Term Debt	-	-	-	-	4.88	-
Current Portion of Leases	2.85	2.72	2.51	2.55	2.27	0.96
Current Unearned Revenue	-	-	0.6	0.6	0.59	0.56
Other Current Liabilities	0.27	14.21	3.25	0.73	1.76	4.65
Total Current Liabilities	39.98	48.51	39.17	22.17	32.62	18.31
Long-Term Debt	-	-	-	-	35.07	45.05
Long-Term Leases	22.8	22.33	20.36	20.05	19.49	1.44
Other Long-Term Liabilities	1.14	2.94	2.6	0.08	0.14	0.02
Total Liabilities	63.92	73.77	62.12	42.3	87.31	64.82
Common Stock	0.91	0.9	0.79	0.65	0.61	0.55
Additional Paid-In Capital	1,486	1,451	1,203	946.15	825.79	489.93
Retained Earnings	-1,158	-959.37	-713.78	-491.91	-322.84	-183.14
Treasury Stock	-	-	-0.05	-	-	-0.05
Comprehensive Income & Other	0.21	0.32	-0.36	-0.16	-0.04	0.02
Total Common Equity	329.77	492.57	489.69	454.72	503.52	307.3
Shareholders' Equity	329.77	492.57	489.69	454.72	503.52	307.3
Total Liabilities & Equity	393.69	566.34	551.81	497.02	590.82	372.12
Total Debt	25.64	25.04	22.87	22.6	61.7	47.45
Net Cash (Debt)	210.02	348.13	333.53	366.14	421.02	256.67
Net Cash Growth	-49.02%	4.38%	-8.91%	-13.04%	64.03%	56.23%
Net Cash Per Share	2.24	4.14	4.89	5.79	7.60	5.24
Filing Date Shares Outstanding	91.16	90.5	79.35	64.51	61.78	55.07
Total Common Shares Outstanding	91.12	90.28	79.12	64.51	61	54.77
Working Capital	201.77	329.72	324.89	369.89	454.73	289.45
Book Value Per Share	3.62	5.46	6.19	7.05	8.25	5.61
Tangible Book Value	265.47	428.27	424.81	423.91	472.7	276.48
Tangible Book Value Per Share	2.91	4.74	5.37	6.57	7.75	5.05
Machinery	48.74	44.58	35.61	25.21	19.84	2.36
Construction In Progress	-	-	-	-	-	27.81
Leasehold Improvements	7.3	6.72	0.59	0.41	0.03	0.03

Source: S&P Capital IQ. Standard template. Financial Sources.